Celloss Biotech
Celloss Biotech develops antibodies for the treatment of fibrotic diseases related to inflammatory proteins secreted outside cells.
Operating in biotechnology, medical, pharmaceutical based in Asia-Pacific (APAC), Celloss Biotech was founded in 2018.
As a business in biotechnology, medical, pharmaceutical, Celloss Biotech is listed here with the public details available about it.
Its base of operations is Asia-Pacific (APAC).
Its current recorded stage is Private company.
Its team size is recorded as c_00001_00010 employees.
| Sector | Biotechnology, Medical, Pharmaceutical |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2018 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: celros.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account